angiotensin ii, des-phe(8)- has been researched along with Fatty Liver, Nonalcoholic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ajambo, M; Albdeirat, L; Albekairi, N; Ali, R; Alotaibi, H; Amanya, G; Attia, H; Badr, A; Elayeete, S; Ghaffar, A; Harris, JR; Hussain, R; Kadobera, D; Khan, A; Kwesiga, B; Li, K; Li, X; Mwanje, W; Nampeera, R; Nansikombi, HT; Naseem, S; Nsubuga, EJ; Rajab, R; Riolexus, AA; Soliman, A | 1 |
Cao, X; Liu, JY; Shi, TT; Song, LN; Xin, Z; Yang, JK; Zhang, YC | 1 |
1 trial(s) available for angiotensin ii, des-phe(8)- and Fatty Liver, Nonalcoholic
1 other study(ies) available for angiotensin ii, des-phe(8)- and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Down-Regulation; Glycolipids; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2020 |